Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 22 Carcinoma, Renal Cell 19 HIV Infections 6 Acquired Immunodeficiency Syndrome 6 Sarcoma, Kaposi 5 Leukemia 5 Neoplasm Metastasis 4 Lymphoma 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Neoplasms 3 Kidney Neoplasms 3 Hematologic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Mycosis Fungoides 2 Multiple Myeloma 2 Leukemia, Myeloid, Chronic-Phase 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Brain Neoplasms 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Tumor Virus Infections 1 Thrombocythemia, Essential 1 Solid Cancers 1

Interventions

Vinorelbine 1 Interferon alpha-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Neoplasm × Interferon alpha-2 × Clear all

NCT00908869 2012-01-30

METRO1

Institut Paoli-Calmettes

Phase 1 Completed

Advanced Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡